GTBP / GT Biopharma, Inc. - Net Long/Short Value

GT Biopharma, Inc.
US ˙ NasdaqCM ˙ US36254L2097

GTBP / GT Biopharma, Inc. - Net Long/Short Value
Halaman ini menyediakan nilai bersih long/short untuk setiap kepemilikan institusional yang dilaporkan melalui pengajuan 13F atau NPORT. Untuk menghitung nilai bersih long/short, kami menambahkan nilai ekuitas ke nilai opsi beli (call option) dan mengurangi nilai opsi jual (put option). Dana yang melaporkan posisi short-borrowed akan melaporkan nilai ekuitas sebagai negatif. Posisi long bersih akan memiliki angka positif di kolom long/short bersih, dan posisi short bersih akan memiliki nilai negatif di kolom tersebut.
Pemilik Nilai Ekuitas
($1000)
Nilai Panggilan
($1000)
Masukkan Nilai
($1000)
Posisi Long/Short Bersih
($1000)
Wells Fargo & Company/mn
BlackRock, Inc.
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
Allworth Financial LP
Bank Of America Corp /de/
Hartland & Co., LLC
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Renaissance Technologies Llc
Jones Financial Companies Lllp
Mount Yale Investment Advisors, LLC
Bank Of Montreal /can/
SBI Securities Co., Ltd.
Newbridge Financial Services Group, Inc.
Blue Bell Private Wealth Management, Llc
Geode Capital Management, Llc
Jpmorgan Chase & Co
UBS Group AG
Advisor Group Holdings, Inc.
Front Row Advisors LLC
Morgan Stanley
Bnp Paribas Arbitrage, Sa
DFSU - Dimensional ETF Trust - Dimensional US Sustainability Core 1 ETF
Tower Research Capital LLC (TRC)
Guggenheim Active Allocation Fund
Vanguard Group Inc
FSKAX - FIDELITY CONCORD STREET TRUST - Fidelity Total Market Index Fund
Other Listings
DE:OXIA
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista